Sanofi Fiscal Q3 Adjusted Earnings, Revenue Rise; 2026 Outlook Raised

03:29 AM EDT, 10/30/2026 (MT Newswires) -- Sanofi (SNY) reported fiscal Q3 business net income Friday of 3.55 euros ($3.97) per share, up from 2.91 euros a year earlier. Analysts polled by FactSet expected 2.74 euros. Revenue for the quarter ended Sept. 30 was 14.44 billion euros, up from 12.43 billion euros a year earlier. Analysts expected 13.60 billion euros. The drugmaker upgraded its 2026 outlook and now expects business EPS and sales to grow by mid-teens and low-teens percentages, respectively. Analysts surveyed by FactSet expect EPS of 8.53 euros on revenue of 49.73 billion euros.